TAMPA, Fla., 21 NOVEMBER 2008 – ISPE, a global not-for-profit association of 25,000 pharmaceutical science and manufacturing professionals, announced its 2008 award winners and recognized their contributions to the pharmaceutical industry and the Society. Robert P. Best, ISPE’s President and CEO, presented the honors at the Society’s 2008 Annual Meeting held on 26-29 October in Boca Raton, Florida.
St. Louis, MO--November 21, 2008 – GenoMed, Inc. (Other OTC: GMED.PK), today announced that it has joined www.StockProfile.com, a customized web-based platform showcasing emerging growth stocks.
Strasbourg, France, November 21, 2008 – Transgene today announced that the primary end point has been met in the first step of the ongoing Phase II trial with its immunotherapy product TG1042 (Ad-IFN•) in patients with relapsing primary cutaneous B-cell lymphoma.
PARIS, Nov. 21 /CNW/ - The first melatonergic antidepressant - Valdoxan/Thymanax (agomelatine) - has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for its use in the treatment of adult patients with major depressive disorder.
San Jose, CA – November 21, 2008 - AnaSpec is excited to announce the release of 4 more new phosphospecific anti-Tau antibodies. This represents the industry’s largest collection of anti-Tau antibodies - 17 phosphospecific and 9 non-phosphospecific antibodies.
Denver, CO – November 21, 2008 – John Collar, Chief Operating Officer of Westminster-based Matrilinex, a start up mitochondrial DNA testing lab company, has been named Executive Director of the Colorado BioScience Association (CBSA), effective December 8, 2008.
ENGLEWOOD, Colo., November 21, 2008 – Baxa Corporation has teamed up with industry leaders ClinicalIQ, LLC and Pharmacy OneSource, Inc., to convey a complete compliance solution for the latest updates in United States Pharmacopeia 797 regulations.
NEW YORK, Nov. 21, 2008--Standard & Poor's Ratings Services said today that it withdrew its 'B' corporate credit rating on PharmaNet Development Group Inc. Standard & Poor's also withdrew its 'BB-' issue-level rating and '1' recovery rating on the company's $45 million revolving credit facility due 2009, its 'CCC+' issue-level rating and '6' recovery rating on the company's $143.75 million convertible notes, and all preliminary ratings related to the company's $300 million shelf registration.
PANAMA CITY, Panama, Nov. 21, 2008--The University of Texas M. D. Anderson Cancer Center marked the beginning of a collaborative effort to eradicate breast cancer in Panama through the Partnership for Breast Cancer Awareness and Research of the Americas today at an event with Laura Bush, the First Lady of the United States, and Vivian Fernández de Torrijos, the First Lady of Panama.
DOWNINGTOWN, Pa., November 21, 2008 — ICD Global has selected Michael Horstmann as the latest edition to its expanding sales force. In his new position, Horstmann will focus on securing new business opportunities with companies in the clinical trial industry that can benefit from ICD’s specialized printing, fulfillment and global distribution capabilities.
|
